Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 586.8	$ 542.8
Accounts receivable, less allowance for doubtful accounts	1,225.3	1,275.8
Inventories	2,310.2	2,256.5
Prepaid expenses and other current assets	376.9	352.3
Total Current Assets	4,499.2	4,427.4
Property, plant and equipment, net	2,014.0	2,015.4
Goodwill	9,570.0	9,594.4
Intangible assets, net	7,522.5	7,684.6
Other assets	683.3	405.0
Total Assets	24,289.0	24,126.8
Current Liabilities:
Accounts payable	361.1	362.6
Income taxes payable	178.2	142.4
Salaries, wages and benefits	193.1	260.3
Other current liabilities	1,022.6	1,131.0
Current portion of long-term debt	500.0	525.0
Total Current Liabilities	2,255.0	2,421.3
Deferred income taxes, net	990.2	999.5
Long-term income tax payable	662.6	666.2
Other long-term liabilities	531.3	350.0
Long-term debt	8,310.6	8,413.7
Total Liabilities	12,749.7	12,850.7
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 308.7 million shares in 2019 (307.9 million in 2018) issued	3.1	3.1
Paid-in capital	8,748.1	8,686.1
Retained earnings	9,688.1	9,491.2
Accumulated other comprehensive loss	(183.5)	(187.4)
Treasury stock, 103.9 million shares in 2019 (103.9 million shares in 2018)	(6,721.4)	(6,721.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	11,534.4	11,271.3
Noncontrolling interest	4.9	4.8
Total Stockholders' Equity	11,539.3	11,276.1
Total Liabilities and Stockholders' Equity	$ 24,289.0	$ 24,126.8